eli lilly tirzepatide news today CEO says weight-loss drug shortage to end 'very soon', Bloomberg reports Eli Lilly's tirzepatide injection results

reported that GLS-driven Gln metabolism is a regulator of radiotherapy tolerance in prostate cancer (PCa) and that high expression of GLS 1 and c-MYC, key regulators of Gln, are significantly associated with reduced progression-free survival in prostate cancer patients treated with radiotherapy

Circulation 128(25):28132851 Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio AL, McKenna WJ, Falaschi A, Giacca M, Camerini (1999) Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity

Earley, Ph.D., a researcher at RTI International in Research Triangle Park, N.C., and lead author of the study

Everyone responds differently to GLP-1 medication

This is my first experience with a dermatologist and I could not be more pleased

The peptide bond is a covalent bond established between the carboxyl group of one amino acid and the amino group of another amino acid